BACTANA CORP.

Profile

Company Names

BACTANA CORP.

Addresses

CELL + GENOMICS BUILDING, 400 FARMINGTON AVE., FARMINGTON, CT 06032

CELL + GENOME SCIENCE BUILDING, 1717, 400 FARMINGTON AVE, FARMINGTON, CT 06032

18 LOCUST AVENUE, BOX 96, NEW CANAAN, CT 06840

Phone Numbers

2037161230
203-716-1230

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$1,757,100.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-07-01 
$385,000.00 
$600,000.00 
$215,000.00 
Debt 
2
2020-01-22 
$25,000.00 
$400,000.00 
$375,000.00 
Equity 
1
2018-10-16 
$1,347,100.00 
$1,650,000.00 
$302,900.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RODRIGO 
 
BICALHO 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
BACTANA CORP.
JOHN 
 
KALLASSY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JAGUAR ANIMAL HEALTH, INC.   |  IB DIRECT, LLC   |  BACTANA CORP.   |  TORIGEN PHARMACEUTICALS, INC.   |  STATERA BIOPHARMA, INC.
PETER 
 
LONGO 
DIRECTOR
EXECUE INC   |  FLOOP, INC.   |  CONTINUITY ENGINE, INC.   |  NOVATRACT SURGICAL, INC.   |  ETOUCHES, INC.   |  PAYVERIS, LLC   |  AEROMICS, INC.   |  ACTUALMEDS CORP   |  IRIDIA, INC.   |  BACTANA CORP.   |  RELLEVATE, INC.   |  HOUSTON AMERICAN ENERGY CORP
RANDOLPH 
 
SEIDLER 
DIRECTOR
BACTANA CORP.
CHEN 
 
WANG 
DIRECTOR
SILEGO TECHNOLOGY INC.   |  BACTANA CORP.   |  STEELIKE, INC.
DAVID 
 
WURZER 
DIRECTOR
RETAIL OPTIMIZATION INC.   |  CYVEK, INC.   |  NOVATRACT SURGICAL, INC.   |  EMME E2MS, LLC   |  RENETX BIO, INC.   |  SUMMIT THERAPEUTICS PLC   |  SHORELINE BIOME, LLC   |  BACTANA CORP.   |  ENKO CHEM, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-07-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-07-01 
2020-02-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-22 
2018-10-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
PROPEL(X), INC.
NONE
HUBBLE INVESTMENTS LLC
289415